Applying Strategy and Measuring Impact of Key Population Health - - PowerPoint PPT Presentation

applying strategy and measuring impact of key population
SMART_READER_LITE
LIVE PREVIEW

Applying Strategy and Measuring Impact of Key Population Health - - PowerPoint PPT Presentation

Applying Strategy and Measuring Impact of Key Population Health Activities DATE HFMA Tri-State Institute September 12, 2019 Session Objectives Learn how to bring a strategic orientation to one of the most operationally leveraged capabilities


slide-1
SLIDE 1

DATE HFMA Tri-State Institute September 12, 2019

Applying Strategy and Measuring Impact of Key Population Health Activities

slide-2
SLIDE 2

DATE

2

Session Objectives

Learn how to bring a strategic orientation to one of the most operationally leveraged capabilities in population health - care management

▪ Recognize the importance of aligning a highly operational

clinical capability to an organization's broader value-based strategy

▪ Understand an approach to measuring the impact of clinical

interventions and effectively disseminating the resulting, nuanced insights

slide-3
SLIDE 3

DATE

3

Agenda

Front Health – background Anticipating key financial roadblocks in VBC transitions A thoughtful approach to care management Measuring the impact of clinical interventions

slide-4
SLIDE 4

DATE

4

Who we are

Greg Long, MD CMO

greg.long@fronthealth.com

▪ Greg has deep population health and

physician leadership expertise and partners with clients to help them achieve success in their value-based care transformation

▪ Greg is a board-certified Family Medicine

physician with more than 25 years of clinical and executive experience, including 10 years as CMO of ThedaCare, a progressive, integrated health system in Wisconsin

▪ Prior to that, he helped lead ThedaCare’s

primary care division through care model redesign resulting in the best clinical quality performance in the state of Wisconsin

▪ We were born from the Midwest

Health Collaborative (MHC), a consortium of six health systems throughout Ohio1, dedicated to delivering exceptional clinical

  • utcomes and increased

satisfaction at lower costs

▪ We incubated our solutions at

MHC and demonstrated their value within our member systems’ at-risk populations

▪ Front Health, a team of analysts,

strategists, designers, and clinicians, now offers these solutions to payers and providers committed to transforming healthcare

1: Cleveland Clinic, OhioHealth (Columbus), ProMedica (Toledo), Premier (Dayton), TriHealth (Cincinnati), and Aultman (Canton)

slide-5
SLIDE 5

DATE

5

How we work with organizations

Our focus has been on high value capabilities that best enable success in value-based care

Data visualization that surfaces meaningful insights is a part of our DNA

▪ Building a stronger

performance improvement “muscle”

▪ Maximizing contract

performance

▪ Creating consistent and data

driven care management

▪ Measuring the impact of

clinical programs

Primary focus of today’s discussion

Performance improvement Rapid and in-depth performance diagnostic and improvement program against individual populations (e.g., EHP) and/or high impact capabilities Contract management Achieving

  • perational

simplicity while managing inherent contractual complexity

Chronic Condition Breakdown Allowed PMPM1, 2017 $107 $449 $81 $32 $30 $26 $21 $20 $19 $17 $13 $13 $71 Hypertension Healthy Active Cancer Diabetes w/o CAD Neurological Disorders Chronic musculoskeletal/ OA/ Osteoperosis All other (12) Total Mental Health/ Substance Abuse Asthma Severe heart failure/ transplant/ heart disease Renal Failure Severer Rheumatic Disease 1% 11%
  • 12%
  • 15%
3% 6% 13%
  • 20%
  • 12%
11% 0% 64% 4% 3% 5% 2% 3% 4% 4% 1% 0% 1% % of total PMPM % diff. from MHC, 2017 Service-line Breakdown Allowed $ PMPM, 2017 $69 $449 $39 $37 $35 $34 $29 $21 $21 $20 $19 $125 PULM GYN DERM All other (12) NEURO ENT ENDO GI CARDIO ORTHO Total PSYCH
  • 1%
  • 1%
  • 16%
13% 2% 28% 3% 2% 8% 0% % of total PMPM % diff. from MHC, 2017 Waste/misuse by system % waste of total PMPM , 2017 5.3% 6.2% 4.0% 2.7% 5.1% System 3 System 1 CCF System 4 System 2 $3.89 $ Allowed Waste PMPM

Service lines & episodes General waste/ misuse Chronic conditions

CONTRACT / POP 3 Metrics/standards

Quality measure 2

Quality measure 9

Quality measure 10

Quality measure...

Quality measure 20

Risk adj. standard 1 CONTRACT / POP 2 Metrics/standards

Quality measure 1

Quality measure 4

Quality measure 7

Quality measure...

Quality measure 25

Risk adj. standard 1 CONTRACT / POP 1 Metrics/standards

Quality measure 1

Quality measure 2

Quality measure 3

Quality measure...

Quality measure 20

Risk adj. standard 1 CONTRACT 3 CONTRACT 2 CONTRACT 1

Pt w/gaps Pt w/gaps, in care mgmt.

slide-6
SLIDE 6

DATE

6

Agenda

Front Health – background Anticipating key financial roadblocks in VBC transitions A thoughtful approach to care management Measuring the impact of clinical interventions

slide-7
SLIDE 7

DATE

7

1: Cost, Quality and Experience, i.e., the Triple Aim; 2: PCMH = Patient-Centered Medical Home; 3: CM = Care Management; 4: BH = Behavioral Health

Design and deploy VBC care model(s) Predict systemic P + L fluctuations Description Understand impact

Analyze outcomes for each VBC intervention

Apply statistical methods to ensure validity

Study and adjust until desired results

Segment populations

Customize care for each segment

PCP-led team models, e.g., PCMH2, CM3, BH4, PharmD

Virtual care options

Strive for net neutral care team costs, e.g., increase panel size for team

Account for all VBC payments

Estimate FFS losses with improved care

Focus on new patient growth

Use data to influence decisions

Maximize

  • perational care

standards

Use best practice care models

Standardize when possible

Create transparency of performance by team member

Study and adjust until desired results 1

Proactively managing the value-based care (VBC) transition will increase confidence in achieving a return1 on the transformational investment

2 3 4

Key Elements Realized value

Invest in proven VBC delivery models in a fiscally responsible way Create leader and operational visibility to the system profitability impact of the VBC transformation; informed adjustments as necessary Ensure clinical team resources are highly productive and effective in achieving desired VBC outcomes Objectively assess the effectiveness of each VBC clinical intervention; informed adjustments as necessary

slide-8
SLIDE 8

DATE

8

Agenda

Front Health – background Anticipating key financial roadblocks in VBC transitions A thoughtful approach to care management Measuring the impact of clinical interventions

slide-9
SLIDE 9

DATE

9

A best in class care management function delivers on a range of key elements

CARE MANAGEMENT

A singular, well-coordinated team that is connected to the primary care givers with resources aligned to reflect population prioritization Org construct & staffing Sophisticated stratification that leverages key data sets and evolves

  • ver time to incorporate increasing access to add’l data (e.g., social

determinants)—for care mgmt, end of life discussions, general risk Risk stratification

Defined measures of success

Clear visibility into daily operational metrics

Systematic view of impact and insight into what drives impact for further program refinement Performance reporting:

  • perational + impact

A compelling message to patients that drives enrollment

An end to end patient engagement and management model that empowers patient to understand and effectively manage their health

A model that balances ongoing patient involvement with the need to maximize the impact across many patients Interventions

Engage/enroll

Assess

Develop plan

Manage

Graduate

Organizational buy-in and support of care management with a clearly defined strategy for where and how (e.g., programs) you want to apply CM

A roadmap where/when resources will be applied (populations) Strategy: populations & programs Key characteristics Key outcomes

Program design

Prioritization of populations Model to align staffing by population Customized risk stratification and patient prioritization

Successful enrollment approach

Targeted interventions based on disease state

Maximizing impact through defined & flexible graduation criteria

Operational dashboard

Systematic impact tracking End to end approach to Care Management This comprehensive approach is easily adapted to improve any system’s or payer’s care management operation

slide-10
SLIDE 10

DATE

10

The first step in a care management strategy is defining where—and to what extent—you are supporting a given population

STRATEGY

Highest priority Population (in order of priority) Total lives (est.) Employee Health Plan 6,000 MSSP 31,400 Medicaid 5,000 Payer 1 MA 5,300 Anthem (CML + MA) 18,000 Aetna (MA) 2,500 MMO (MA) 13,000 ~85,000 ILLUSTRATIVE Payer 2 CML 5,300 High risk support Rising risk support What are the right programs for a specific population to maximize impact? Further, where do you set the “dials”

  • n each of those

programs?

slide-11
SLIDE 11

DATE

11

It’s important to think through the construct of your operation and define the level of standardization expected at each step

STRATEGY

Level of standardization (in this example) High All will use the same stratification definitions coming

  • ut of Platform ABC

High Agree on the minimum programs to offer and ideal levels of staffing Medium Specific pathways and processes defined together, but execution and implementation are local responsibilities High Mutual accountability to each other for patient, financial, and care manager performance Strategy + org (e.g., programs, resources) Stratification of patients Delivery of care management (interventions) Performance /

  • utcomes

Facilitate alignment around common programs & levels of support, incl. a formula for defining staffing Role of the “central” function Propose, refine, implement, and train the local systems on the stratification methodology Lead development of interventions for specific conditions; create standards for hiring/training Align the group on metrics and goals, provide ongoing transparency to performance Local entity role Population-specific decisions on programs & level of support (beyond minimum) Provide input into the methodology and educate own system

  • n how it works

Lead the day to day

  • perations/delivery of CM

resources Hold each other accountable to your performance HEALTH SYSTEM EXAMPLE

slide-12
SLIDE 12

DATE

12

With programs defined, the next step is to determine the optimal number of resources required, which can inform broader financial VBC modeling

STAFFING MODEL

Population + program inputs Workload inputs Staffing model output 1

Population growth Competition PSA capture SSA capture Outmigration Net new patients

Market share growth

% % % % % Admissions Readmissions ED visits Imaging OP procedures

FFS Revenue Losses

$$ $ $$$ $$ $ CPC + CCM TCM Shared savings Quality payment Downside risk

Value-based contract revenue

$$ $ $$$ $$ $ $$$ MD/DO APP RN/CM Behavioral Pharmacy Diabetes ed.

Care transformation resources

FTE xxx xx xx xx x xx

System profitability predictor for VBC 2

slide-13
SLIDE 13

DATE

13

Description Requirement Primary Criteria Severity/ Disease status

Severity of patients current health status as determined by presence of current or previous health diagnosis’

At least one

HCC-RAF >=2

Pts with depression

Pts with stroke condition

Pts with CKD

Last eGFR <60

30 day readmission High utilizers/ High Cost

Current and continued use

  • f acute ED & IP services

which impact high total cost of care

At least one

ED visits >=3

Hospital admits >=2

Allowed amounts >=10K without surgical spend Predictive risk

Probability that patient will continue to be a high utilizer based on predictive models

At least one

Inpatient stay probability (based on 12 months of claims) >=10%

Likelihood of DM admit >= 80%

Likelihood of CHF admit >= 80%

Likelihood of COPD admit >= 80%

AND AND

Identifying patients can be done any number of ways; what’s most important is ensuring that it’s informed by the types of patients you seek to engage

RISK STRATIFICATION

Severity/ disease status Utilization High cost Impactable factors Predictive risk Health status based on current or previously diagnosed health issues High risk Current and continued use

  • f acute ED & IP services

High total cost of care that we can impact due to unnecessary utilization Probability that patient will continue to have poor health outcomes based on predictive models Patients with current high cost, high utilization, and predicted continued poor health status who would benefit from intervention Probable future use of acute ED & IP services Current low cost with a potential for future increases that we can impact by avoidance Rising risk Severity probable worsening health status determined by predictive models which will increase cost from unnecessary utilization without intervention Patients whose predicted health status is worse than their historical cost and utilization would suggest Health status at time of discharge, including acuity of admission, discharge diagnosis’, comorbidities, and cognition History of admissions and readmissions Patient has been discharged on new medications or DME that will be crucial to maintain health or continue recovery Transitional Probability of readmission in the next 3 months based on risk score Patients who are being discharged from the hospital after an acute event who are not predicted to maintain their health or continue recovery Patients with newly diagnosed chronic conditions (within the last 6 months) or multiple comorbidities

A few critical steps to stratification…

  • Define the types of patients you seek

to engage

  • Create criteria that enables

identifying those types of patients

  • Develop a way to prioritize identified

patients The goals of a program define the types of patients to engage…

Organizaion- specific

…and should inform the stratification criteria

slide-14
SLIDE 14

DATE

14

▪ Near real-time view of how efficient

care managers (e.g., engagement, graduation rates; panel size) are w/ability to cut in multiple ways

▪ Comparative reports across multiple

dimensions to identify top performers/areas and those with room for improvement Operational performance/ efficiency Outcomes: financial and utilization—Impact tracking

▪ Patient outcomes across cost and

key utilization measures: – Cost (Allowed PMPM – Utilization (ED, IP admits, PCP visits, high-tech radiology)

A best in class CM function can provide near real-time insight into

  • perational performance and measures patient impact

PERFORMANCE

Key types of performance transparency Description 3 4

slide-15
SLIDE 15

DATE

What is my current workload? What populations are patients from? How long have patients been in the program? How is the panel distributed across my team? What kind of patients are enrolled?

slide-16
SLIDE 16

DATE

How well am I enrolling new patients?

slide-17
SLIDE 17

DATE

How well am I graduating patients?

slide-18
SLIDE 18

DATE

18

Agenda

Front Health – background Anticipating key financial roadblocks in VBC transitions A thoughtful approach to care management Measuring the impact of clinical interventions

slide-19
SLIDE 19

DATE

19

▪ Near real-time view of how efficient

care managers (e.g., engagement, graduation rates; panel size) are w/ability to cut in multiple ways

▪ Comparative reports across multiple

dimensions to identify top performers/areas and those with room for improvement Operational performance/ efficiency Outcomes: financial and utilization— Impact tracking

▪ Patient outcomes across cost and

key utilization measures: – Cost (Allowed PMPM – Utilization (ED, IP admits, PCP visits, high-tech radiology)

A best in class CM function can provide near real-time insight into

  • perational performance and measures patient impact

IMPACT TRACKING

Key types of performance transparency Description 3 4 The challenges that exist…

▪ Payers, health systems, and self-

insured employers spend meaningful dollars on care interventions -– care management, disease-specific programs, etc. –

▪ However, these investments lack

an adequate understanding of their actual impact – either because they aren’t done (due to analytical difficulty, confounding variables) or they are done poorly

▪ Instead, you are often forced to

rely on either gut feel or insufficient approaches that could be leading to the wrong conclusion altogether

slide-20
SLIDE 20

DATE

20

Significant investments in care interventions require reliable insights to understand their impact and inform a broader value-based strategy

IMPACT TRACKING

▪ Pairing a strategic understanding of

population health with a robust set of analytics to methodically answer the most important – and difficult – questions – What is the impact of your clinical interventions / investments? (e.g., care management, disease management, social determinants of health) – Given those insights, what are the implications to your value-based strategy?

▪ Creating visibility to the impact you’ve

been having – or not, and help you maximize it going forward

% difference – pre and post intervention

Intervened group Matched control Statistically significant difference

▪ A repeatable, comprehensive approach that

delivers statistically-validated insights

▪ Robust matching of intervened and control

patients, including addressing selection bias

▪ Consistent approach across all clinical

interventions

▪ Best in class visualization to surface nuanced

insights

Single population example; see appendix for multiple population synthesis

slide-21
SLIDE 21

DATE

21

A narrow or incomplete view of impact can easily lead to the wrong conclusion, often with major strategic implications

Potential conclusions Example: PMPM impact Discontinue intervention due to perceived lack of impact on cost; Hold on to FFS contracts as long as you can Model cost savings expected on the high cost segment of any population you expect to manage; Insights drive an expansion of risk contracts moving forward What a customer thinks is happening… …what is actually happening PMPM among care managed patients is increasing by 20% in the year after enrollment % difference – pre and post intervention PMPM is increasing by 20%...but control patients are increasing by 80%

Intervened group Intervened group Matched control Statistically significant difference

slide-22
SLIDE 22

DATE

22

Provider case study. Impact tracking – care navigation

  • 100
  • 75
  • 50
  • 25

25 50 75 100

Matched (CM’d) - 49 Matched (control) - 49

Admits ED Imaging PCP Rx PMPM % change in performance – pre vs. post enrollment (or similar if control group)

MSSP population

Difference of matched patients is statistically significant

slide-23
SLIDE 23

DATE

23

Provider case study. Impact tracking – CMS annual wellness visits

Statistical analysis + dashboard design

▪ Situation: Provider lacked visibility into

the impact of CMS annual wellness visits

▪ Challenge: Needed expertise to perform

statistical analysis to determine efficacy

  • f the AWV + method to track outcomes
  • ngoing

▪ Outcomes: Demonstrated avoided

utilization + cost in those CMS beneficiaries with a regular cadence of AWVs; confidence in recommending resources to improve AWV compliance

▪ Statistically valid insights ▪ Repeatable approach ▪ Best-in-class visualizations

slide-24
SLIDE 24

DATE

24

Wrap up and questions QUESTIONS?